Skip to content

Fascia Iliaca Compartment Block Versus Anterior Quadratus Lumborum Block

A Comparative Study Between Postoperative Analgesia of Fascia Iliaca Compartment Block and Anterior Quadratus Lumborum Block in Proximal Femur Fracture

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04709211
Enrollment
128
Registered
2021-01-14
Start date
2021-01-10
Completion date
2021-07-01
Last updated
2024-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

Fractures of the femur are common orthopaedic emergency especially in the geriatric population and central neuraxial blocks are the preferred technique for providing anaesthesia. However, limb immobility and extreme pain are the deterrents for ideal positioning for these procedures. postoperative pain is a nightmare so adequate analgesia has been advocated to reduce the pain. in this study, Facia Iliaca compartment block will be compared to anterior Quadratus lumborum block, both will be done Ultrasound-guided using Bupivacain0.25% for postoperative analgesia at the end of the surgery.

Detailed description

In this prospective, randomized, comparative study patients will be equally divided into two equal groups; GroupI: patients will receive Ultrasound-guided Facia Iliaca compartment block with 50 ml 0.25%bupivacaine at the end of surgery Group Q: patients will receive Ultrasound-guided anterior Quadratus lumborum block with 50 ml 0.25%bupivacaine at the end of surgery

Interventions

patients will receive Ultrasound-guided Facia Iliaca block using 50 ml 0f Bupivacaine 0.25%

PROCEDUREAnterior Quadratus Lumbroum block

patients will receive Ultrasound-guided Anterior Quadratus Lumbroum block using 50 ml 0f Bupivacaine 0.25%

DRUGbupivacaine

bupivacaine

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* ASA II to IV * Both sexes * scheduled for fracture femur surgeries

Exclusion criteria

* patients with bleeding disorders and coagulopathy * infection at the injection site * known allergy to local anaesthetics * patients with multiple fractures * patients with pre-existing myopathy or neuropathy * patients with significant cognitive dysfunction * patients who receive long-acting opioids preoperatively

Design outcomes

Primary

MeasureTime frameDescription
first request of analgesia48 hours postoperativethe time the patient felt pain and asked for analgesics

Secondary

MeasureTime frameDescription
total opioid consumption48 hours postoperativetotal dose of fentanyl used

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026